MetaVia Inc. filed a current report on November 18, 2026, disclosing that it received a written notice from Nasdaq on November 17, 2026, stating the company no longer satisfies the minimum stockholders' equity requirement for continued listing on The Nasdaq Capital Market.
Key Highlights
- Deficiency notice received: Nasdaq notified MetaVia on November 17, 2026, that it does not comply with Nasdaq Listing Rule 5550(b)(1), which requires minimum stockholders' equity of $2.5 million.
- Equity fell below threshold: The company's stockholders' equity, as reported in its quarterly report for the period ended September 30, 2026, has fallen below $2.5 million.
- Alternative standards not met: According to the filing, the company does not meet the alternative compliance standards referenced in the Nasdaq notice.
- Compliance plan deadline: MetaVia has 45 calendar days from the notice date, or until January 4, 2027, to submit a plan to regain compliance.
- Possible extension: If Nasdaq accepts the plan, the company may receive an extension of up to 180 calendar days from the date of the notice to evidence compliance.
- Listing continues: The notice has no immediate impact on the listing of MetaVia's common stock, which continues to trade on The Nasdaq Capital Market under the symbol NASDAQ:MTVA.
MetaVia Discloses Stockholders' Equity Drop Below Nasdaq's $2.5 Million Threshold
MetaVia Inc., a Delaware-incorporated company headquartered at 545 Concord Avenue, Suite 210, Cambridge, Massachusetts, disclosed that its stockholders' equity as reported in the quarterly filing for the period ended September 30, 2026, has fallen below the $2.5 million minimum required under Nasdaq Listing Rule 5550(b)(1). The filing states that the company also does not meet the alternative compliance standards cited in the Nasdaq notice. Hyung Heon Kim, President and Chief Executive Officer, signed the report on behalf of the registrant.
According to the filing, MetaVia intends to timely submit a compliance plan to Nasdaq within the 45-calendar-day window, which expires on January 4, 2027. The filing notes that if Nasdaq accepts the submitted plan, the exchange may grant an extension of up to 180 calendar days from the date of the notice for the company to demonstrate that it has returned to compliance. The filing contains forward-looking statements regarding the compliance process, which the company identifies as subject to significant risks and uncertainties, including no assurance that any submitted plan will be accepted by Nasdaq or that compliance will ultimately be regained.
The filing clarifies that the receipt of the deficiency notice carries no immediate effect on the trading status of the company's common stock, par value $0.001 per share, which continues to be listed on The Nasdaq Capital Market under the ticker NASDAQ:MTVA. The company was incorporated in Delaware and carries IRS Employer Identification Number 47-2389984 and Commission File Number 001-37809.
What Was Disclosed
MetaVia Inc. reported receiving a Nasdaq deficiency notice on November 17, 2026, citing failure to meet the $2.5 million minimum stockholders' equity standard. The company has until January 4, 2027, to submit a compliance plan, and trading under NASDAQ:MTVA continues without immediate interruption.



Please wait processing your request...